Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
Price:
25.84 USD
0.94%
Market Closed
Updated:
May 5, 2024
Mirum Pharmaceuticals Inc
Cash from Financing Activities
|
Mirum Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
|
Cash from Financing Activities
$336.6m
|
CAGR 3-Years
23%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Financing Activities
-$17.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Financing Activities
-$5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Financing Activities
$21B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Financing Activities
-$562.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Financing Activities
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-88%
|
CAGR 10-Years
N/A
|
See Also
What is Mirum Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
336.6m
USD
336.6m
USD
Based on the financial report for Dec 31, 2023, Mirum Pharmaceuticals Inc's Cash from Financing Activities amounts to 336.6m USD.
What is Mirum Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
41%
41%
Over the last year, the Cash from Financing Activities growth was 209%. The average annual Cash from Financing Activities growth rates for Mirum Pharmaceuticals Inc have been 23% over the past three years , 41% over the past five years .
You don't have any saved screeners yet
